A protein-based pentavalent inhibitor of the cholera toxin B-subunit

Angew Chem Int Ed Engl. 2014 Aug 4;53(32):8323-7. doi: 10.1002/anie.201404397. Epub 2014 Jul 2.

Abstract

Protein toxins produced by bacteria are the cause of many life-threatening diarrheal diseases. Many of these toxins, including cholera toxin (CT), enter the cell by first binding to glycolipids in the cell membrane. Inhibiting these multivalent protein/carbohydrate interactions would prevent the toxin from entering cells and causing diarrhea. Here we demonstrate that the site-specific modification of a protein scaffold, which is perfectly matched in both size and valency to the target toxin, provides a convenient route to an effective multivalent inhibitor. The resulting pentavalent neoglycoprotein displays an inhibition potency (IC50) of 104 pM for the CT B-subunit (CTB), which is the most potent pentavalent inhibitor for this target reported thus far. Complexation of the inhibitor and CTB resulted in a protein heterodimer. This inhibition strategy can potentially be applied to many multivalent receptors and also opens up new possibilities for protein assembly strategies.

Keywords: carbohydrates; glycoproteins; multivalency; protein modifications; protein structures.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bacteria / metabolism*
  • Binding Sites
  • Carbohydrates
  • Cholera Toxin / chemistry*
  • Glycoproteins
  • Models, Molecular
  • Proteins

Substances

  • Carbohydrates
  • Glycoproteins
  • Proteins
  • Cholera Toxin